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Abstract
Objectives. To evaluate the efficacy of endoscopic dacryocys-
torhinostomy (Endo-DCR) in the treatment of acute
dacryocystitis with lacrimal sac empyema (ADLSE).
Design. Case series with chart review.
Setting. Academic tertiary center.
Patients. The study included 26 consecutive patients who
underwent Endo-DCR for ADLSE between August 2005
and December 2013.
Main Outcome Measures. The success of the procedure was
defined as complete complaint relief and DCR patency. Data
on the time from referral to surgery, postoperative compli-
cations, and revision surgery are also reported.
Results. The present patient series included 4 males (15.4%)
and 22 females (84.6%) (mean age, 66 years). The mean
time between referral and surgery was 0.88 days and the
mean follow-up time was 29 months. All patients showed
immediate relief from symptoms, with no ADLSE recur-
rences. Complete success was achieved in 25 (96.2%) cases;
the only failure was in a patient who had previously under-
gone radioiodine treatment. In this case, revision Endo-DCR
was not successful. The only perioperative complication
(3.8%) was epistaxis in a patient who required revision sur-
gery under general anesthesia. The definitive success rate
was 96.2% after primary and revision surgery.
Conclusions. Endo-DCR enables rapid resolution of ADLSE
with a very high success rate. Immediate surgery may
reduce the risk of skin fistulization and/or orbital complica-
tions. DCR shrinkage and lacrimal obstruction are unlikely
with Endo-DCR since the procedure is performed on an
enlarged sac. The main advantage of Endo-DCR, compared
with external DCR, is the absence of a skin incision in an
inflamed and infected field.
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Introduction
Epiphora, eyelid and lacrimal sac swelling, purulent secre-
tion from canaliculi, and recurrent dacryocystitis are typical
complaints in patients affected by occlusion of the lacrimal
pathway. Acute dacryocystitis is a presenting modality in a
substantial proportion of patients with lacrimal pathway
obstruction and is characterized by a well-defined swelling
at the medial canthus. When this swelling has ill-defined
borders and the sac is massively dilated and covered by
hyperemic and congested skin that is possibly associated
with eyelid edema (Figure 1), the term acute dacryocystitis
with lacrimal sac empyema (ADLSE) would seem to be the
more appropriate description of this condition.
Historically, conventional treatment for ADLSE con-
sisted of prolonged systemic antibiotics together with warm
compresses and percutaneous incision and drainage of the
lacrimal sac empyema.1 Surgical treatment, that is, external
dacryocystorhinostomy (Ex-DCR),2 was generally delayed
for weeks after resolution of acute infection to avoid having
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to make a skin incision in an infected field1,3,4 and possibly
spreading the infection along tissue planes.5
In the last 15 years, transnasal endoscopic DCR has
changed some common trends in managing lacrimal path-
way pathologies. Among these, the possibility of treating
ADLSE without the need for a delayed, planned surgery is
the most relevant. In the presence of ADLSE, immediate
transnasal endoscopic DCR (Endo-DCR) may lead to rapid
resolution of infection without a skin incision and may also
help decrease the duration of antibiotic therapy with a rea-
sonably limited hospitalization time.2
The aim of the present study was to evaluate the efficacy
of immediate Endo-DCR in the treatment of ADLSE based
on a retrospective review of patients treated in a single aca-
demic tertiary center.
Materials and Methods
This study obtained local institutional review board
approval. A database dedicated to patients with obstruction
of the lacrimal pathway who were evaluated at the
Department of Ophthalmology and surgically treated at the
University of Brescia Department of Otorhinolaryngology
from August 2005 to December 2013 was retrospectively
analyzed. Only patients treated by Endo-DCR for ADLSE
with a minimum 6-month follow-up were considered eligi-
ble for this study. In the same period, all patients with acute
dacryocystitis without clinical signs suggesting lacrimal sac
empyema were immediately treated with oral antibiotics
and antibiotic-steroid eye drops. Delayed Endo-DCR was
planned if the diagnostic workup confirmed a lacrimal path-
way obstruction.
Information was collected regarding gender, age, previ-
ous surgery, clinical history, comorbidities, possible risk
factors for lacrimal pathway obstruction and procedural fail-
ure (chemotherapy, radiotherapy [RT] on the sinonasal tract,
radioiodine treatment, Wegener’s granulomatosis, and other
autoimmune conditions), and retreatment in case of recur-
rence. All patients considered eligible for surgery underwent
computed tomography of the sinonasal tract. In contrast to
elective Endo-DCR, dacryocystography (DCG) was not per-
formed for ADLSE cases, since the occurrence of lacrimal
sac abscesses is considered to be a consequence of a post-
saccal stenosis. Systemic broad-spectrum intravenous anti-
biotic treatment was started at admission and was prolonged
until discharge; in the presence of marked edema and
absence of specific contraindications, intravenous steroid
was also administered (methylprednisolone 20 mg intrave-
nously once daily for 1-2 days). Thereafter, oral antibiotics
were administered for 8 days.
The main outcomes to evaluate the success of Endo-DCR
were complete resolution of the specific complaints (ie, lacri-
mal sac infection and epiphora) and DCR patency, the latter
being assessed in each patient by transnasal endoscopic
examination and lacrimal pathway irrigation; when the
patient still complained of epiphora, DCG was also per-
formed. Other outcomes such as hospitalization time, peri-
and postoperative complications, and the need for revision
surgery were analyzed to assess the efficacy of the approach.
Surgical Indications and Technique
Surgery was performed under general anesthesia using both
0 and 45 telescopes. When a septal spur or deviation pre-
vented access to the sac area, septoplasty was performed.
The mucosa corresponding to the projection of the lacrimal
sac was infiltrated with 2 mL of adrenaline diluted
1:100,000, and a posteriorly pedicled mucoperiosteal flap
was harvested and posteriorly displaced. Once the lacrimal
bone and the adjacent portion of the maxillary sinus frontal
process were exposed, the bone overlying the lacrimal sac
was removed. Once the entire medial wall of the lacrimal
sac was exposed, a reverse H-shape incision was made on
the medial wall of the lacrimal sac with an angled knife
(Figure 2). The 2 resulting mucosal flaps were then gently
folded anteriorly and posteriorly to cover the bone around
the sac itself (Figure 3A). The previously harvested muco-
periosteal flap was anteriorly rotated and then longitudinally
incised to obtain 2 smaller flaps that were used to cover the
bone superiorly and inferiorly to the sac (Figure 3B and
Figure 4). The flaps were positioned with smooth instru-
ments, and a small amount of absorbable haemostatic
Figure 1. Typical clinical appearance of acute dacryocystitis with
lacrimal sac empyema (ADLSE) with marked, ill-defined swelling in
margins and swelling at the medial cantus. Hyperemic skin covering
the enlarged lacrimal sac and eyelid edema may also be present.
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gelatin sponge (Spongostan, Ethicon Inc, Somerville, New
Jersey) was used to keep them in place.
A lacrimal stent was positioned in selected cases such as
difficult revision surgery, granulomatous diseases, small sac
size, and previous RT or radioiodine treatment and in
patients with limited compliance or who were unavailable
for regular follow-up. In the absence of risk factors for
bleeding, nasal packing was not used.
Postoperative Surveillance and Follow-up
On the first postoperative day, an endoscopic examination
of the nasal cavity was performed to remove fibrin and
blood clots and to check the patency of the DCR. Lacrimal
pathway irrigation was performed in all cases except those
with a lacrimal stent. After discharge from the hospital, the
patient was instructed to perform daily nasal irrigations with
saline solution and to apply emollient ointment twice daily
for 2 weeks. In addition, antibiotic-steroid eye drops were
administered twice daily for 2 weeks. Endoscopic debride-
ment and lacrimal irrigations were repeated on the seventh
postoperative day. In the presence of satisfactory DCR heal-
ing, the patient was scheduled for regular endoscopic eva-
luations (every 3 months for the first year, every 6 months
for the second year). In the presence of abundant scar tissue
and/or irregular DCR healing, a stricter follow-up was
scheduled. The stent was kept in place for 1 to 3 months
depending on associated pathological factors, length of heal-
ing process, and sac size.
According to the classification of Zuercher et al,6 com-
plete success was defined as DCR patency upon transnasal
endoscopic examination with complete resolution of symp-
toms. Symptom relief with DCR obstruction was considered
a functional success, whereas DCR patency and persistent
complaints were defined as an anatomic success. Finally,
the association of DCR stenosis with persistent complaints
was considered a surgical failure. As previously stated, all
cases were evaluated by endoscopy and lacrimal irrigation,
and in the presence of epiphora, DCG was planned to assess
the site of the obstruction.
Results
The analysis included 4 (15.4%) males and 22 (84.6%)
females with a mean age of 66 years (range, 28-98 years).
The most frequently reported complaints were painful swel-
ling of the medial canthus and inferior eyelid associated
with epiphora.
Figure 2. Nasal endoscopy on left side, 0 endoscope: After its
complete exposure, the lacrimal sac medial wall (Ls) is incised by
an angled knife (Ak) with evidence of pus drainage. NS, nasal
septum. Asterisk indicates posteriorly rotated mucosal flap.
Figure 3. (A) Nasal endoscopy on left side, 45 endoscope: Once
the sac is incised, the mucosa obtained from the lacrimal sac (Ls)
medial wall is folded to cover the bone posteriorly (1) and ante-
riorly (2) to the sac itself. The bone (b) inferior to the sac will be
covered with the mucosal flap (asterisk) that will be anteriorly
rotated. (B) Nasal endoscopy on left side, 45 endoscope: The pre-
viously harvested mucosal flap (asterisk) is longitudinally incised to
obtain 2 smaller flaps that will be used to cover the bone super-
iorly (3) and inferiorly (4, which will be rotated and positioned) to
the lacrimal sac (Ls).
Figure 4. Nasal endoscopy on the left side, 45 endoscope:
Surgical field at the end of the procedure with the 2 last mucosal
flaps in place and no residual bone exposed. Ls, lacrimal sac; 3 and
4, third and fourth flap obtained by longitudinal incision of the pre-
viously harvested mucosal flap.
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The clinical history included up to 20 previous episodes
of acute dacryocystitis treated with various combinations of
antibiotics and in 5 (19.2%) cases drainage with percuta-
neous aspiration and/or surgical incision. Only 2 (7.7%)
patients had previously submitted to Ex-DCR. Risk factors
for lacrimal pathway obstruction were identified in 6
(23.1%) patients: chemotherapy in 3 patients (11.5%) and
external beam RT, radioiodine treatment, and psoriatic
arthritis in 1 patient each (3.8%).
The mean time between referral and surgery was 0.88
days (range, 0-3 days), such that the majority of patients
underwent Endo-DCR on the same day as admission.
Septoplasty was required in 3 (11.5%) patients. The mean
hospitalization time was 2.54 days (range, 1-6 days), while
the mean and median follow-up time was 29 and 18
months, respectively (range, 6-102 months).
All patients reported immediate relief from pain and gra-
dual improvement of medial canthus swelling and edema
(Figure 5). In 10 (38.5%) cases, a bicanalicular silicone
tube was positioned, either because of the presence of risk
factors for procedural failure (5 cases, 19.2%) or because
the patients were considered to be poorly suitable for post-
operative medications (5 cases, 19.2%). The tube was
removed after a mean period of 30 days. In term of compli-
cations, only one 83-year-old woman (3.8% of cases), who
had also undergone septoplasty, presented postoperative
epistaxis, which was successfully controlled by endoscopic
coagulation under general anesthesia. This patient had dif-
fuse bleeding from the nasal septum and lateral nasal wall
mucosa that required revision under general anesthesia due
to very low patient compliance.
No recurrence of ADLSE was observed in the follow-up
period; 3 additional patients were not included in the analy-
sis due to a follow-up period that was shorter than 6
months. Complete functional success was achieved in 25
(96.2%) patients (Figure 6). The only failure with DCR
obstruction and persistent epiphora occurred in a woman
who had undergone radioiodine treatment for thyroid gland
carcinoma 12 years before Endo-DCR. The first Endo-DCR
was performed on the left side without positioning a stent.
The patient recovered from pain and no recurrence of
ADLSE was described, although she was referred with per-
sistent mild epiphora thereafter. Transnasal endoscopic
examination and DCG confirmed that there was an obstruc-
tion of the DCR. Two years after the primary treatment,
revision of the left DCR was performed and a silicone tube
positioned. The tube on the left side was removed 6 months
later, but unfortunately the revision DCR also failed. A
DCG performed 1 year after revision surgery showed the
presence of pre-saccal stenosis.
Discussion
In recent years, considerable efforts have been made to
determine whether Ex-DCR or Endo-DCR is preferred for
treating lacrimal pathway obstruction. To date, the common
opinion is that the 2 approaches, whenever properly planned
and performed, are characterized by comparable functional
outcomes.7,8
The comparison should therefore entail some adjunctive
factors, such as the cosmetic importance of a facial skin
incision and scar. Even though a report focusing on this spe-
cific issue demonstrated that only a very limited number of
patients (4%) were worried about a scar following Ex-
DCR,9 the risk of bad scar formation undeniably exists and
is often unpredictable.2 Moreover, at least in our experience,
many patients, when presented with 2 approaches that have
comparable functional outcomes, are more inclined to prefer
the one leaving no visible scar. Endo-DCR may also allow
concomitant correction of sinonasal anomalies (septal devia-
tion) that could compromise the functional outcome.10
Figure 5. Clinical appearance of a patient with ADLSE the day
before (A) and after (B) surgery; the medial canthus swelling and
skin hyperemia are considerably reduced.
Figure 6. Nasal endoscopy on left side, 45 endoscope.
Endoscopic appearance of a perfectly healed, broad dacryocystor-
hinostomy without exposure of residual bone. MT, middle
turbinate.
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Finally, additional advantages of a transnasal endoscopic
procedure include a magnified surgical field and avoidance
of medial canthus ligament sectioning with consequent
pump mechanism preservation.11,12
Endo-DCR is considered feasible even in the presence of
an ADLSE with the possibility of immediately treating
abscesses, rapid resolution of infection, limited hospitaliza-
tion time, and no need for planned lacrimal surgery.2
In the past, some experiences supported immediate Ex-
DCR as a reliable option for treating ADLSE.13 However,
to date the general tendency for those who prefer an exter-
nal approach is to administer antibiotics and perform sur-
gery only after the infection is resolved in order to avoid
making a skin incision in an infected field and spreading
inflammation through the dissected planes.14
When dealing with ADLSE, the preference for Endo-
DCR is based on the possibility of immediate treatment
offered by a transnasal approach. We agree with Madge
et al2 that this procedure is not, in itself, an emergency sur-
gery needed within hours since ADLSE is not a life-
threatening condition. However, our preference for immedi-
ate surgery is dictated by 2 main reasons: The risk of skin
fistulization, which could result in undesirable scarring in
the medial canthus area, is reduced, and immediate interven-
tion can decrease the risk of orbital complications that,
despite their rarity, may have catastrophic consequences.
Such complications typically include cellulitis and subper-
iosteal, extra- and intraconal abscesses, the latter possibly
leading to optic neuropathy with risk of vision disturbance
and even loss.15,16
In our experience, treatment of ADLSE with early intra-
venous broad-spectrum antibiotic administration and imme-
diate Endo-DCR was effective. Endo-DCR allows exposure
and opening of the lacrimal sac on the nasal side, thereby
reducing dissection in infected and inflamed soft tissues.
The risk of orbital complications and the duration of treat-
ment and hospitalization are therefore reduced. Even the
risk of bleeding following surgery in an infected field is
very low. We experienced only 1 postoperative epistaxis;
this complication, as already stated, was a diffuse venous
rather than an arterial bleeding that, during endoscopic
DCR, is generally related to a lesion of the angular artery or
a branch of the anterior ethmoidal artery.
Regarding economic benefits, patients treated with early
Endo-DCR were shown to have significantly shorter hospi-
talization time than those treated according to a ‘‘conven-
tional’’ schedule, with important implications in terms of
cost and patient morbidity.2 However, the total health costs
of our approach, including hospitalization time and post-
operative surveillance, were not assessed, and the cost-
effectiveness ratio of our protocol should be better defined,
possibly in a prospective way.
When one is analyzing the functional results of Endo-
DCR in ADLSE, there are 3 main outcomes to be evaluated:
absence of relapsing lacrimal sac infection, resolution of
epiphora, and DCR patency. As highlighted by Madge
et al,2 in the 5 publications that focus on this topic, the
results of Endo-DCR in the treatment of ADLSE are not
uniform.2,4,10,17,18 Notably, in these studies complete resolu-
tion of lacrimal sac infection was achieved in all cases,
although epiphora and lacrimal pathway obstruction per-
sisted at rates ranging from 5.6% to 33%.2,4,10,17,18 Lee and
Woog17 analyzed 24 patients treated endoscopically with a
hybrid technique (powered drill and then YAG laser) and
found that ostium patency and absence of epiphora were
obtained in 83% of patients. Causes of failure were identi-
fied as granuloma formation around the ostium in 1 case
and membranous obstruction of the ostium in the remaining
3 cases. Morgan et al10 performed laser-assisted endoscopic
DCR in 9 patients with acute dacryocystitis and obtained
functional and anatomical success in only 67% of cases,
with the remaining 3 cases having persistent complaints and
showing a stenotic ostium with fibrous tissue. Duggal et al4
treated 11 patients with acute dacryocystitis with abscess
formation by endoscopic DCR under local anesthesia using
cold instruments; subjective improvement of symptoms and
lacrimal pathway patency was achieved in 72.7% and
81.8% of patients, respectively. Wu et al,18 in a prospective
randomized study, analyzed a cohort of 72 patients with
acute dacryocystitis, of whom 40 were treated endoscopi-
cally and 32 were treated by an external approach, with the
second group of patients treated 1 to 2 weeks after resolu-
tion of acute inflammation. Ostium patency was achieved in
90% of patients treated endoscopically and in 65.7% of
cases in the external group. Notably, the duration of acute
inflammation was significantly shorter with an endoscopic
approach. Causes of failure following an endoscopic proce-
dure were intranasal ostium closure and common canalicu-
lus obstruction in 3 and 1 case, respectively.
Madge et al,2 in their retrospective, multicenter study,
reported excellent results with an endoscopic approach, as
94.4% of patients were free of epiphora with a patent lacri-
mal pathway. The only failure was observed in a patient for
whom, due to intraoperative bleeding, the status of the
mucosal flaps was suboptimal.
Our results compare favorably with the data in the litera-
ture, with 96.2% of patients in this study having no residual
complaints. Some speculations may be offered to explain
this favorable outcome. Considering surgical technique,
wide exposure of the lacrimal sac medial wall and the use
of mucosal flaps to cover the drilled bone may have played
a role in minimizing the healing process. The incomplete
exposure of the sac leads to harvest of a small DCR, with
the consequent risk of occlusion. From this perspective, it is
essential to completely remove the bone over the sac with a
drill or cutting instruments. Our surgical technique, which
has been slightly modified over the years, now entails the
use of a diamond-bur (4 mm) with intermittent saline irriga-
tion to minimize heat damage. Similarly, to reduce heat
damage to soft tissues, we do not use a laser to harvest the
mucosal flap or incise the lacrimal sac wall. Satisfactory
exposure also requires preventive correction of possible ana-
tomic variants, such as septal deviation, before approaching
the sac, thus favoring not only the surgical procedure but
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also postoperative medications. Moreover, the presence of
an agger nasi cell medial to the lacrimal sac as well as the
modality of insertion of the uncinate process on the lateral
nasal wall must be preoperatively assessed.19 According to
the technique described by Tsirbas and Wormald,11 we also
elevate a posteriorly based mucoperiosteal flap before
removing the bone covering the medial wall of the lacrimal
sac.
Thereafter, minimizing the area of exposed bone around
the sac that remains uncovered at the end of surgery is
essential, since this is precisely the site where a granuloma
is more likely to develop. We generally cover the bone by
mucosal rotational flaps according to a technique that, with
some minor differences, has already been described and is
intended to favor primary intention healing.11,12,20,21 When
allowed by anatomic conditions, we harvest 4 flaps, with 2
obtained by extroversion of the lacrimal sac mucosa and 2
by a posteriorly based mucoperiosteal flap.
When one is treating ADLSE, the large size of the lacri-
mal sac may be helpful in obtaining sufficient mucosal
tissue to cover the bone and reducing the risk of ostium
shrinkage and obstruction. In contrast, when limited lacri-
mal sac dimensions are present, the 2 flaps obtained by the
mucoperiosteal flap are harvested and positioned, and with
such a condition, a lacrimal bicanalicular stent may also be
helpful. Interestingly, in the literature there is no general
consensus about the use of mucosal flaps, and recent publi-
cations have reported excellent functional results without
harvesting them.22 Notably, the only failure we described in
this study occurred in a woman in whom a well-known risk
factor for lacrimal pathway restenosis was identified. This
patient reported resolution of acute dacryocystitis, whereas
epiphora persisted despite revision surgery and stent posi-
tioning. DCG performed after stent removal revealed the
presence of a pre-saccal stenosis that might have resulted
from improper lacrimal pathway management during irriga-
tions or surgery or pre-saccal pathway involvement by the
inflammatory process that gave rise to acute dacryocystitis.
It is possible that some of the patients reported in the litera-
ture with patent DCR and persistent epiphora, but not recur-
rent lacrimal sac infection, may also have had an occult pre-
saccal stenosis.
Conclusion
The present study demonstrates that Endo-DCR enables a
rapid resolution of ADLSE with a very high success rate.
Immediate surgery reduces the need for prolonged therapy
and may prevent skin fistulization and/or orbital complica-
tions. DCR shrinkage and lacrimal obstruction are unlikely
since the procedure is performed on an enlarged sac. While
our study lacks a control group treated with a more conser-
vative approach, given the excellent outcome of our treat-
ment protocol, we would consider it unethical to offer
patients an alternative treatment that might include an exter-
nal incision of the sac to drain the empyema and/or an
external DCR.
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